Dreaden Receives Winship Collaborative Pilot Grant

*********************************
There is now a CONTENT FREEZE for Mercury while we switch to a new platform. It began on Friday, March 10 at 6pm and will end on Wednesday, March 15 at noon. No new content can be created during this time, but all material in the system as of the beginning of the freeze will be migrated to the new platform, including users and groups. Functionally the new site is identical to the old one. webteam@gatech.edu
*********************************

Atlanta, GA | Posted: January 11, 2021

Two teams win funding intended to spark innovations that improve lives of cancer patients

Contact

Joshua Stewart

404.385.2416

Sidebar Content
No sidebar content submitted.
Summaries

Summary Sentence:

Two research teams win funding intended to spark innovations that improve lives of cancer patients.

Full Summary:

Two research teams win funding intended to spark innovations that improve lives of cancer patients.

Media
  • Erik Dreaden Erik Dreaden
    (image/jpeg)

By Shannon McCaffrey, Emory Health Sciences

Two research teams from Winship Cancer Institute of Emory University (Winship) have been awarded pilot grants from the Donaldson Charitable Trust Research Synergy Fund, a unique funding opportunity offered jointly by Winship, the Aflac Cancer and Blood Disorders Center of Children's Healthcare of Atlanta, and the Wallace H. Coulter Department of Biomedical Engineering at Georgia Tech and Emory University.

Each one-year grant of $125,000 is funded in part by contributions from the Oliver S. and Jennie R. Donaldson Charitable Trust. The grants are intended to spark collaboration between basic science researchers (including biomedical engineers) and physicians, leading to innovations that improve the lives of children and adults with cancer.

This cycle's Donaldson Charitable Trust Research Synergy Fund pilot grant recipients are:

"Improving CAR T cell efficacy through optimal manufacturing with nanoparticle backpacks"

  • Sarwish Rafiq, PhD (Principal Investigator)
    Assistant Professor, Department of Hematology and Medical Oncology
    Emory University School of Medicine
  • Erik Dreaden, PhD (Co-Principal Investigator)
    Assistant Professor, Wallace H. Coulter Department of Biomedical Engineering
    Georgia Institute of Technology and Emory University
    Assistant Professor of Pediatrics
    Emory University School of Medicine
    Aflac Cancer and Blood Disorders Center of Children's Healthcare of Atlanta

“MERTK and MEK inhibitor combination therapy for AML”

  • Deborah DeRyckere, PhD (Principal Investigator)
    Assistant Professor, Department of Pediatrics
    Emory University School of Medicine
    Aflac Cancer and Blood Disorders Center of Children's Healthcare of Atlanta
  • Nicki Panoskaltsis, MD, PhD, FRCP (Co-Principal Investigator)
    Associate Professor, Department of Hematology and Medical Oncology
    Emory University School of Medicine

Visit Winship Awards & Pilot Grants for more information about pilot grants and other funding opportunities for Winship investigators.

Related Links

Additional Information

Groups

Wallace H. Coulter Dept. of Biomedical Engineering

Categories
No categories were selected.
Related Core Research Areas
No core research areas were selected.
Newsroom Topics
No newsroom topics were selected.
Keywords
Erik Dreaden, Emory Winship Cancer Institute
Status
  • Created By: Joshua Stewart
  • Workflow Status: Published
  • Created On: Jan 11, 2021 - 2:30pm
  • Last Updated: Jan 11, 2021 - 2:30pm